Tag: Ali Satvat

SunFire announces investment from KKR

SunFireMatrix, Inc. (SunFire), a leading software and tech-enabled services platform serving the insurance distribution and health plan markets, announced that it has been acquired by funds managed by KKR, a leading global investment firm. Funds managed by Stone Point Capital LLC, the Company’s previous majority owner, will continue to be a significant minority shareholder in the Company.…

KKR to invest in Precipart

KKR, a global investment firm, announced that it has agreed to invest in Precipart, a leading contract manufacturer of precision components for the medical device and aerospace industries. KKR plans to support the Company in its continued growth organically and through M&A. Financial terms were not disclosed, a statement said. Founded in 1950 by the…

KKR to invest in life sciences firm Catalio Capital Management

KKR, a global investment firm, announced an agreement to invest in Catalio Capital Management, LP, a multi-strategy investment firm focused on breakthrough biomedical technology and innovative health care companies. The addition of new capital is expected to accelerate Catalio’s growth trajectory and talent acquisition, as well as anchor its investment strategies. Pursuant to the agreement, KKR…

Azurity Pharmaceuticals acquires KKR-backed Slayback Pharma

Azurity Pharmaceuticals, Inc. (Azurity) announced the closing of its acquisition of Slayback Pharma LLC (Slayback) from existing investors including KKR, a leading global investment firm, and Everstone Capital. Slayback is now a wholly-owned subsidiary of Azurity. The acquisition brings together companies with complementary strengths, enhancing Azurity’s ability to realize its purpose of Serving Overlooked Patients. The…

Slayback Pharma announces investment of $50 mn by the Everstone Group

Slayback Pharma LLC has announced an agreement with The Everstone Group (“Everstone”) to invest up to US$50 million in Series B funding.  The new capital will be used to expand and accelerate further Slayback’s already rich and differentiated pipeline of complex generic and specialty pharmaceutical products. In addition to the investment, Everstone Managing Directors Arjun…